Log In
BCIQ
Print this Print this
 

RV03

  Manage Alerts
Collapse Summary General Information
Company Intellect Neurosciences Inc.
DescriptionAlzheimer's disease (AD) vaccine targeting beta amyloid and delta tau proteins
Molecular Target Beta amyloid
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Peptide vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/23/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today